Hospital Acquired Disease Testing Market to Exhibit 19.90% CAGR from 2015 to 2023 - Transparency Market Research

News provided by

Transparency Market Research

11 Jan, 2016, 14:00 GMT

ALBANY, New York, January 11, 2016 /PRNewswire/ --

According to a new market report published by Transparency Market Research "Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023", the global hospital acquired disease testing market was valued at US$0.4 bn in 2014 and is expected to grow at a CAGR of 19.9% from 2015 to 2023, to reach an estimated value of US$2.0 bn by 2023.

Browse the full Hospital Acquired Disease Testing Market (Pneumonia, UTI, Blood Stream, Surgical Site, MRSA Infection, and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/hospital-acquired-disease-testing.html

Nosocomial infections/hospital acquired diseases/hospital associated infections (HAI) form one of the critical areas of focus in the healthcare industry. Factors such as rising prevalence of such conditions in neonatal and geriatric population, initiatives taken up by governments to manage nosocomial infections, increasing number of diseases that surges risk of hospital associated infections, and growing concerns about control and prevention of nosocomial infections worldwide will have a positive impact on the current hospital acquired disease testing industry.

Get Sample Report Copy of Hospital Acquired Disease Testing Market:  

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1759

The global hospital acquired disease testing market is segmented on the basis of tests for pneumonia, urinary tract infection, blood stream infection, surgical site associated infection, MRSA infection testing and others. The hospital acquired urinary tract infection diagnostics segment occupies the largest market share in this category as prevalence and morbidity rate of this condition, and the demand for diagnostic solutions for the same is the highest as compared to other hospital associated infections. It is expected that the global market for hospital associated urinary tract infection testing will continue to dominate the global market till 2023. Furthermore, other testing solutions for conditions such as surgical site infections and pneumonia (hospital associated and ventilator associated infections) will also experience high demand in lesser developed regions of Asia Pacific, Latin America and other developing countries where the prevalence of such conditions is higher.

Molecular diagnostics solutions play a vital role in this market as these offer precise, faster and cost effective diagnosis for various nosocomial infections. Considering the market competition, the global hospital acquired infection testing market is highly fragmented and is characterized by the existence of several large and mid-sized diagnostic solution providers. Some of the key market players contributing to this industry include Diatherix Laboratories Inc., Gen-Probe Inc., Qiagen GmbH, L Hoffman La Roche, Cepheid, Inc., Life Technologies Corporation, Meridian Biosciences, Cantel Medical Corporation, Nordion, Inc. and others.

Browse Press Release of Hospital Acquired Disease Testing Market: http://www.transparencymarketresearch.com/pressrelease/hospital-acquired-disease-testing.htm  

Key companies studied and profiled in this report include Baxter International Inc., Bio-Medical Research (BMR) Ltd., Boston Scientific Corporation, Codman & Shurtleff, Inc., DJO Global, Inc., Halyard Health, Hospira, Inc., Medtronic plc, St. Jude Medical, Smiths Medical, and Stryker Corporation. Collaborative agreements, product launches, and acquisitions are analyzed to be a significant part of business stratagems that are usually being adopted by global players to strengthen and secure their position in the market.

The global hospital acquired disease testing market is segmented as follows:
 

Global Hospital Acquired Disease Testing Market, by Test 

  • Pneumonia infection
  • Urinary tract infection
  • Blood stream associated infection
  • Surgical site infection
  • MRSA infection
  • Others 

Global Hospital Acquired Disease Testing Market, by Geography 

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Browse Regional Analysis: http://www.europlat.org/global-hospital-acquired-disease-testing-market-to-reach-us2-0-bn-by-2023-led-by-u-s-and-canada.htm

Other Reports by Transparency Market Research:  

About Us:  

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact:

Mr. Sudip.S
90 State Street, Suite 700
Albany, NY 12207
United States.
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Blog: http://www.tmrblog.com/

SOURCE Transparency Market Research